Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Majoon Suranjan
- Development stage
- Phase 3
- Lead developer
- Dawakhana Tibbiya
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Majoon Suranjan is a traditional polyherbal Unani formulation widely used for its anti-inflammatory, analgesic, and anti-arthritic properties. It is primarily indicated for the management of joint disorders, including rheumatoid arthritis, osteoarthritis, gout, sciatica, and general musculoskeletal pain. The formulation typically contains a blend of medicinal herbs, with *Colchicum luteum* (Suranjan Shirin/meadow saffron) as its chief active ingredient, which is rich in colchicine. Other key components often include *Zingiber officinale* (Zanjabeel/ginger), *Operculina turpethum* (Turbud Safaid), and *Cassia angustifolia* (Sana), which work synergistically to reduce joint swelling, alleviate pain, lower uric acid levels, and promote mobility. It is manufactured and distributed by various traditional medicine developers, including Dawakhana Tibbiya College (Aligarh Muslim University) and Hamdard.
- Brand names
- Cipzer Majoon SuranjanDawakhana Tibbiya Majoon SuranjanHamdard Majun SuranjanRex Majun Suranjan
- Other names
- Majoon-e-SuranjanMajun SuranjanMajun-e-Suranjan
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on Majoon Suranjan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Majoon Suranjan.